Tango Therapeutics Inc

NASDAQ:TNGX   10:33:06 AM EDT
9.81
-0.28 (-2.78%)
Earnings Announcements

Tango Therapeutics Reports Third Quarter 2021 Financial Results

Published: 11/09/2021 12:19 GMT
Tango Therapeutics Inc (TNGX) - Tango Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights.
Q3 Loss per Share $0.28.
Revenue Was $6.8 Million for Q3 Compared to $(11.3) Million for the Same Period in 2020.
Q1 Earnings per Share View $-0.26, Revenue View $5.6 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $6.57 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $5.6 Million
Next Quarter EPS Guidance is expected to be -$0.29

More details on our Analysts Page.